T0	Population 25755 25849	surveys did not ask whether individuals ever injected drugs or ever shared injection equipment
T1	Population 26000 26111	we underestimated the number of participants who engaged in these behaviors and who may be at high risk for HCV
T2	CompositeIntervention 26126 26247	the number of people achieving subsequent steps of the HCV care continuum (eg, linkage to care, and treatment initiation)
T3	OutcomeMeasures 26744 26817	not allow us to estimate reinfection or HCV treatment failure experiences
T4	NonstandardTreatmentCharacteristics 26850 26981	participants to advance to the latest stage, achieving SVR, during the study period if they had received treatment before the study
T5	VerySpecificPopulation 27247 27310	enrollment challenges at 2 of the 3 addiction treatment centers
T6	VerySpecificPopulation 27389 27467	97% of participants were recruited from 1 center in the state of Massachusetts
T7	Generalization 27469 27498	limiting the generalizability
T8	Setting 27514 27574	The primary treatment center is located in an urbanized area
T9	Population 28020 28080	only 2 participants were recruited in the state of Wisconsin
T10	PrecisionOfMeasurement 28342 28364	the use of self-report
T11	RelevantOutcomeExcluded 28889 28946	if serologic confirmation of HCV could have been obtained
T12	PrecisionOfMeasurement 29057 29087	most test dates were estimated
